UMediC Group Berhad (0256.KL)
- Previous Close
0.7200 - Open
0.7150 - Bid 0.7150 x --
- Ask 0.7200 x --
- Day's Range
0.7050 - 0.7200 - 52 Week Range
0.7050 - 0.7200 - Volume
937,500 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.95
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It also offers products, such as patient monitoring system, women and childcare, MR compatible monitoring solution, hospital furniture, life-support solution, anaesthesia solution, resuscitation care, critical care solution, ultrasound solution, and oxygen therapy and suction solution. In addition, the company provides services, including clinical training on equipment, planned preventive maintenance, installations, equipment pre-checks, equipment servicing and repair, 24/7 emergency call-out, unlimited break down call, and spare parts procurement. The company was formerly known as UMediC Group Sdn Bhd and changed its name to UMediC Group Berhad in September 2021. UMediC Group Berhad was incorporated in 2021 and is headquartered in Penang, Malaysia. UMediC Group Berhad is a subsidiary of UMediC Capital Sdn Bhd.
www.umedic.com.myRelated News
Compare To: 0256.KL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0256.KL
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
19.71%
Return on Assets (ttm)
9.71%
Return on Equity (ttm)
16.09%
Revenue (ttm)
49.6M
Net Income Avi to Common (ttm)
9.77M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
17.33M
Total Debt/Equity (mrq)
1.83%
Levered Free Cash Flow (ttm)
-4.82M
Research Analysis: 0256.KL
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 0256.KL
0256.KL does not have Company Insights